42 Genetics Ltd Filleted accounts for Companies House (small and micro)

0 false false false false false false false false false true false false false false false false No description of principal activity 2021-03-01 Sage Accounts Production Advanced 2021 - FRS102_2021 xbrli:pure xbrli:shares iso4217:GBP NI658976 2021-03-01 2022-02-28 NI658976 2022-02-28 NI658976 2021-02-28 NI658976 bus:Director3 2021-03-01 2022-02-28 NI658976 core:WithinOneYear 2022-02-28 NI658976 core:WithinOneYear 2021-02-28 NI658976 core:AfterOneYear 2022-02-28 NI658976 core:AfterOneYear 2021-02-28 NI658976 core:RestatedAmount 2021-02-28 NI658976 bus:Micro-entities 2021-03-01 2022-02-28 NI658976 bus:AuditExempt-NoAccountantsReport 2021-03-01 2022-02-28 NI658976 bus:FullAccounts 2021-03-01 2022-02-28 NI658976 bus:SmallCompaniesRegimeForAccounts 2021-03-01 2022-02-28 NI658976 bus:PrivateLimitedCompanyLtd 2021-03-01 2022-02-28

COMPANY REGISTRATION NUMBER: NI658976

42 Genetics Ltd

Filleted Unaudited Financial Statements

28 February 2022

42 Genetics Ltd

Statement of Financial Position

28 February 2022

	2022	2021
	£	£
Fixed assets	835,070	194,538
	---------	---------

Current assets	178,706	6,963

Creditors: amounts falling due within one year	83,465	44,800
	---------	---------
Net current assets/(liabilities)	95,241	( 37,837)
	---------	---------
Total assets less current liabilities	930,311	156,701

Creditors: amounts falling due after more than one year	43,333	150,000

Accruals and deferred income	15,000	–
	---------	---------
	871,978	6,701
	---------	---------

Capital and reserves	871,978	6,701
	---------	-------

For the year ending 28 February 2022 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;

- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .

These financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

These financial statements were approved by the board of directors and authorised for issue on 16 February 2023 , and are signed on behalf of the board by:

Mr N Moen

Director

Company registration number: NI658976

The company is a private company limited by shares, registered in Northern Ireland. The address of the registered office is 42 Genetics Limited, Innovation Centre, Queens Road, Belfast, BT3 9DT, Northern Ireland.